Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $14678.4.

  • Molecular Partners Ag's Total Current Liabilities rose 2187.14% to $14678.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $14678.4, marking a year-over-year increase of 2187.14%. This contributed to the annual value of $12260.5 for FY2024, which is 9992.46% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Total Current Liabilities stood at $14678.4, which was up 2187.14% from $15578.2 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Total Current Liabilities ranged from a high of $50.8 million in Q4 2021 and a low of $9971.3 during Q1 2025
  • Moreover, its 5-year median value for Total Current Liabilities was $18173.7 (2022), whereas its average is $8.7 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 9992.42% in 2024, then skyrocketed by 2187.14% in 2025.
  • Over the past 5 years, Molecular Partners Ag's Total Current Liabilities (Quarter) stood at $50.8 million in 2021, then plummeted by 64.77% to $17.9 million in 2022, then decreased by 9.24% to $16.3 million in 2023, then tumbled by 99.92% to $12312.5 in 2024, then grew by 19.22% to $14678.4 in 2025.
  • Its Total Current Liabilities stands at $14678.4 for Q3 2025, versus $15578.2 for Q2 2025 and $9971.3 for Q1 2025.